- Home
- GV vs CYCC Comparison
GV vs CYCC Comparison
Compare GV & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- CYCC
- Stock Information
- Founded
- GV 2013
- CYCC 1992
- Country
- GV Canada
- CYCC Malaysia
- Employees
- GV N/A
- CYCC N/A
- Industry
- GV Other Consumer Services
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- CYCC Health Care
- Exchange
- GV Nasdaq
- CYCC Nasdaq
- Market Cap
- GV 7.8M
- CYCC 7.8M
- IPO Year
- GV 2022
- CYCC N/A
- Fundamental
- Price
- GV $1.88
- CYCC $9.05
- Analyst Decision
- GV
- CYCC
- Analyst Count
- GV 0
- CYCC 0
- Target Price
- GV N/A
- CYCC N/A
- AVG Volume (30 Days)
- GV 2.9M
- CYCC 5.2M
- Earning Date
- GV 08-19-2025
- CYCC 08-18-2025
- Dividend Yield
- GV N/A
- CYCC N/A
- EPS Growth
- GV N/A
- CYCC N/A
- EPS
- GV N/A
- CYCC N/A
- Revenue
- GV $7,773,905.00
- CYCC $14,000.00
- Revenue This Year
- GV N/A
- CYCC $137.21
- Revenue Next Year
- GV N/A
- CYCC N/A
- P/E Ratio
- GV N/A
- CYCC N/A
- Revenue Growth
- GV N/A
- CYCC N/A
- 52 Week Low
- GV $1.00
- CYCC $3.08
- 52 Week High
- GV $9.60
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- GV 55.96
- CYCC 46.14
- Support Level
- GV $1.02
- CYCC $7.21
- Resistance Level
- GV $1.65
- CYCC $10.08
- Average True Range (ATR)
- GV 0.26
- CYCC 2.10
- MACD
- GV 0.07
- CYCC -0.26
- Stochastic Oscillator
- GV 70.44
- CYCC 14.53
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.